# Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure

> **NCT05633758** · PHASE2 · WITHDRAWN · sponsor: **Scripps Health**

## Conditions studied

- Acute Decompensated Heart Failure

## Interventions

- **DRUG:** Placebo
- **DRUG:** Metolazone

## Key facts

- **NCT ID:** NCT05633758
- **Lead sponsor:** Scripps Health
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-03
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no participants enrolled
- **Last updated:** 2022-12-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05633758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05633758, "Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05633758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*